BUSINESS

More news
Biogen, based in Cambridge, Massachusetts, had revenues of $13.4 billion last year and finished 2020 with about 9,100 employees

Samsung In Talks To Buy Biogen For $42 Bn: Report

Biogen, which is known for its Alzheimer's drug Aduhelm and a neurology-focused medication pipeline, reportedly approached Samsung on a potential deal that could be valued at more than $42 billion.

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.